My bookmarksSign up free
Source

2012/141/EU: Commission Implementing Decision of 6 March 2012 on the financing of emergency surveillance measures for rabies in northern Greece (notified under document C(2012) 1354)

2012/141/EU: Commission Implementing Decision of 6 March 2012 on the financing of emergency surveillance measures for rabies in northern Greece (notified under document C(2012) 1354)

Decision · 7 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The ‘Emergency plan for the surveillance of rabies’ submitted by Greece to the Commission on 27 January 2012 (‘the plan’) is hereby approved for the grant of a Union financial contribution for the period from 27 January 2012 to 31 December 2012 (‘the financial contribution’).

Article 2

Open ↗

1.   The financial contribution shall not exceed, in total, EUR 60 000. 2.   The financial contribution shall include a lump sum of EUR 5 per wild animal collected and sent for rabies investigation under the plan. 3.   The financial contribution shall be at the rate of 75 % of the costs to be incurred under the plan for the laboratory tests for the detection of rabies infection and for the isolation and characterisation of rabies virus. Those costs shall include: (a) the costs paid for the purchase of test kits, reagents and all consumables used to carry out the laboratory tests; (b) overheads equal to 7 % of the total sum of the costs referred to in point (a). However, the maximum amount of the costs to be reimbursed for a fluorescent antibody test (FAT) shall not exceed, in total, EUR 12 per test. 4.   The financial contribution shall be at the rate of 75 % of the costs for personnel specifically hired for carrying out the laboratory tests referred to in paragraph 3. Those costs shall include: (a) the fee paid for the personnel or their actual salaries plus social security charges and other statutory costs included in their remuneration; (b) overheads equal to 7 % of the total sum of the costs referred to in point (a). However, the maximum amount of the costs to be reimbursed for such personnel shall not exceed, in total, EUR 25 000.

Article 3

Open ↗

1.   The financial contribution shall be granted provided that Greece: (a) implements the plan in accordance with the relevant provisions of Union law, including rules on competition, the award of public contracts and State aid; (b) submits interim technical reports to the Commission in accordance with Annex I by the latest on: (i) 31 May 2012, covering the period from 27 January 2012 to 30 April 2012; (ii) 30 September 2012, covering the period from 1 May 2012 to 31 August 2012; (c) submits a final technical report and a financial report in accordance with Annexes I and II, covering the period from 27 January 2012 to 31 December 2012, by the latest on 28 February 2013; (d) implements satisfactorily the measures foreseen in the plan. 2.   In the event that Greece does not comply with the conditions laid down in paragraph 1, the Commission shall reduce the financial contribution taking into account the nature and gravity of the non-compliance and the financial loss incurred by the Union.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I The technical reports referred to in Article 3(1)(b) and (c) shall include at least the following information: Reporting period: from _ to _. Interim technical report  Final technical report  A.    Rabies surveillance tests performed and results: Prefecture Species Test type Number of animals tested Positive                                                             B.    Technical evaluation of the situation and difficulties faced.

ANNEX IISupplementary provisions

Open ↗

ANNEX II The financial report referred to in Article 3(1)(c) shall include at least the following information: Measures eligible for co-financing Laboratory tests   Type of tests Number of animals tested Number of tests carried out Cost of tests carried out without overheads Detection of rabies virus antigen FAT       PCR       other (please specify)       Isolation/Characterisation of rabies virus Sequencing       other (please specify)       Total         Laboratory personnel specifically hired for the purposes of the plan Name Status (Permanent/Temporary) Contract duration Amount paid                                         I certify that: — this expenditure was actually incurred, accurately accounted for and eligible under the provisions of Commission Implementing Decision 2012/141/EU , — no other contribution from the Union was requested for this plan and all revenue accruing from operations under the programme is declared to the Commission , — the plan was executed in accordance with the relevant Union legislation, in particular the rules on competition, the award of public contracts and State aid , — control procedures apply, in particular to verify the accuracy of the amounts declared, to prevent, detect and correct irregularities . Date: Name and signature of operational director:

Other acts of the same type
Council Decision (EU) 2023/1476 of 26 June 2023 on the signing, on behalf of the European Union, and provisional application of the Sustainable Fisheries Partnership Agreement between the European Union and the Republic of Madagascar and its implementing protocol (2023-2027)Council Decision (EU) 2023/1493 of 26 June 2023 establishing the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards the adoption of a decision adding two newly adopted Union acts to Annex 2 to the Windsor FrameworkCouncil Decision (EU) 2023/1494 of 26 June 2023 on the position to be taken on behalf of the European Union within the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community as regards the adoption of a decision to amend Part I of Annex I to that AgreementCouncil Decision (CFSP) 2023/1217 of 23 June 2023 amending Decision 2014/512/CFSP concerning restrictive measures in view of Russia’s actions destabilising the situation in UkraineCouncil Decision (CFSP) 2023/1218 of 23 June 2023 amending Decision 2014/145/CFSP concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCommission Decision (EU) 2023/1313 of 22 June 2023 approving, on behalf of the European Union, the amendments to Annex 14-B of the Agreement between the European Union and Japan for an Economic PartnershipDecision of the European Ombudsman adopting implementing provisionsCommission Implementing Decision (EU) 2023/1198 of 21 June 2023 amending Directive 2008/68/EC of the European Parliament and of the Council on the inland transport of dangerous goods to authorise certain national derogations (notified under document C(2023) 3900) (Text with EEA relevance)Commission Implementing Decision (EU) 2023/1207 of 21 June 2023 renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87701 × MON 89788 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2023) 3935) (Only the text in Dutch is authentic) (Text with EEA relevance)Commission Implementing Decision (EU) 2023/1208 of 21 June 2023 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 95379 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2023) 3936) (Only the Dutch text is authentic) (Text with EEA relevance)Commission Implementing Decision (EU) 2023/1209 of 21 June 2023 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP4114 x MON89034 x MON87411 x DAS-40278-9 and its sub-combinations DAS-40278-9 x DP4114 x MON 87411, MON 89034 x DP4114 x MON 87411, MON 89034 x DAS-40278-9 x MON 87411, MON 89034 x DAS-40278-9 x DP4114, DP4114 x MON 87411, DAS-40278-9 x MON 87411, DAS-40278-9 x DP4114, MON 89034 x DP4114, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2023) 3937) (Only the texts in French and Dutch are authentic) (Text with EEA relevance)Commission Implementing Decision (EU) 2023/1210 of 21 June 2023 renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified cotton 281-24-236 × 3006-210-23 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2023) 3940) (Only the Dutch and French texts are authentic) (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next